Compare DRDB & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DRDB | LFMD |
|---|---|---|
| Founded | 2024 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.8M | 330.5M |
| IPO Year | 2024 | N/A |
| Metric | DRDB | LFMD |
|---|---|---|
| Price | $10.43 | $3.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $10.22 |
| AVG Volume (30 Days) | 16.3K | ★ 1.4M |
| Earning Date | 01-01-0001 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $250,091,814.00 |
| Revenue This Year | N/A | $13.65 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $596.94 | ★ N/A |
| Revenue Growth | N/A | ★ 28.78 |
| 52 Week Low | $9.87 | $3.18 |
| 52 Week High | $10.47 | $15.84 |
| Indicator | DRDB | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 60.21 | 52.86 |
| Support Level | $10.42 | $3.84 |
| Resistance Level | $10.45 | $4.36 |
| Average True Range (ATR) | 0.01 | 0.30 |
| MACD | 0.00 | 0.10 |
| Stochastic Oscillator | 100.00 | 67.78 |
Roman DBDR Acquisition Corp II is a blank check company.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.